{"product_id":"advances-in-telemedicine","title":"Advances in Telemedicine","description":"\u003cp\u003eAdvances in Telemedicine\u003c\/p\u003e \n\n\u003cp\u003eCOVID-19 rapidly accelerated the use of telemedicine technologies and their acceptance by HCPs and patients is now well established. Favourable regulation and rising reimbursement is further seeing telehealth embedded in the healthcare ecosystem. So, where does pharma fit in? Why should pharma be interested in remote patient monitoring? What role can telemedicine play in chronic disease management? In this report experts assess the technologies that are driving change and the innovations which will shape the delivery of healthcare in the future.\u003c\/p\u003e\n\n\u003cp\u003eCompanies\u003c\/p\u003e\n\n\u003cp\u003ePfizer, Fitbit, GE Healthcare, Apple, Amwell, Teladoc, Validic, 23andMe, Aptar Pharma, Alpenglow Biosciences, Enhance3D Genomics, Globant, HealthTap, Medfuture, MedWand Solutions, mWell, Motto, Nonagon, Oracle Cerner, SHL Telemedicine, URAC, White Rock Medical Center\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"November, 2022 \/ - \/ MCW16238922","offer_id":47653820629298,"sku":null,"price":7140.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/advances-in-telemedicine","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}